Eupraxia Pharmaceuticals Inc. ("Eupraxia" or the "Company") , a clinical-stage biotechnology company leveraging its proprietary Diffuspheretm technology designed to optimize local, controlled drug ...

Q3 2025 Earnings Call Transcript November 12, 2025 Lucid Diagnostics Inc. misses on earnings expectations. Reported EPS is ...

Reported late-breaking Phase 2 data at SITC for vilastobart demonstrating a 40% ORR in heavily pretreated patients with MSS mCRC without liver ...

Humacyte, Inc. ( HUMA) Q3 2025 Earnings Call November 12, 2025 8:00 AM EST Good morning, ladies and gentlemen, and welcome to the Humacyte's Third Quarter Results Conference Call. [Operator ...

PAVmed Inc.  ("PAVmed" or the "Company"), a diversified commercial-stage medical technology company, operating in the medical device, diagnostics, and digital health sectors, today provided a business ...

Reported late-breaking Phase 2 data at SITC for vilastobart demonstrating a 40% ORR in heavily pretreated patients with MSS mCRC without liver metastases and high plasma tumor mutational burden Presen ...

Detailed price information for Coherus Oncology Inc (CHRS-Q) from The Globe and Mail including charting and trades.

While gastroesophageal reflux disease affects both men and women, men tend to experience more severe symptoms and ...

A never-before-seen letter penned by a lovestruck passenger on the Titanic reveals that a romance between a real-life Jack ...

By enhancing metabolism and oxygen consumption, the device can help burn more calories during and after each session, aiding ...

The idea of Indian fashion probably gives you a vision of celebrated ethnic brands with an array of iconic and sparkling ...

The modern dating scene feels like it’s running on fumes. Men with half-baked personalities, women juggling five different identities just to stay interesting, and everyone stuck in the same swiping ...